GSK and Merck joining forces for potential cancer treatment
Patients who have recurrent or metastatic solid tumors that are not responding to standard treatment could soon receive helpful treatment with the help of a GSK and Merck joined effort.
Patients who have recurrent or metastatic solid tumors that are not responding to standard treatment could soon receive helpful treatment with the help of a GSK and Merck joined effort.